KEY FINDINGS The North America IBS-C drug market is anticipated to register a CAGR of 8.68% over the projected period, 2020-2028. The region of North America has the most developed healthcare systems and medical devices industry in the world. The government agencies, together with private medical firms, are providing the best medical facilities to patients from all over the world. The drug market is continuously growing in the region, owing to federal government initiatives to improve the healthcare sector by providing the latest technological support and advanced medical treatments.
MARKET INSIGHTS The IBS-C drug market of North America is segregated into the countries of the US and Canada for further surveying the growth in the region.Canada’s statistics and patient conditions are the same as that of the US.
The reason for the growing number of Irritable Bowel Syndrome (IBS) patients in Canada is patients suffering from chronic pain seek analgesics, mostly opioids, to get rid of non-cancer pains and other forms. It was estimated that in 2019 health spending will account for 11.6% of Canada’s GDP. Canada’s health expenditure per person in 2018 was similar to that of Australia, the Netherlands, and France. The prevalence rates of IBS in Canada, which is around 5 million, is one of the highest in the world. IBS is universally known to affect more women than men, and there are medications prescribed specifically for women. The ratio for IBS patients is seven females to two males in Canada. Many drugs are suggested apart from a lifestyle change, dietary intake, and psychological counseling for treating IBS patients. Despite the decreasing average selling prices, a rise in the number of treatments, the prevalence of GI disorders in the growing population, is boosting the growth of this market.
COMPETITIVE INSIGHTS Abbott Laboratories, Astellas Pharma US, Inc., Ardelyx, Synthetic Biologics, Catalent Pharma Solutions, etc. are some of the major companies functioning in the market.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned 1. CATALENT PHARMACEUTICALS SOLUTIONS 2. ABBOTT LABORATORIES 3. NOVARTIS PHARMA AG 4. ASTELLAS PHARMACEUTICALS 5. ARDELYX, INC. 6. SYNTHETIC BIOLOGICS, INC. 7. TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8. BAMA-GEVE, SLU 9. FERRING BV 10. IRONWOOD PHARMACEUTICALS, INC. 11. SALIX PHARMACEUTICALS LTD. 12. NORGINE B.V. 13. PROMETHEUS LABORATORIES, INC. 14. ALBIREO PHARMA, INC. 15. YUHAN CORP. 16. ASTRAZENECA PLC 17. THE MENARINI GROUP 18. ONO PHARMACEUTICAL CO. LTD. 19. ACTAVIS NORDIC A/S
Our reports have been used by over 10K customers, including:
Cholera - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Pipeline Review, H2 2020, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Cholera is an acute infectious disease caused by a bacterium, Vibrio...
218 pages •
By Asia Market Information & Development Company
• Jun 2020
China’s demand for Digestive Remedies has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
Antacids Market Research Report by Formulation (Liquid, Powder, and Tablet), by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents, and Proton Pump Inhibitor), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Antacids Market is expected to grow from USD 6,602.69...
Gastrointestinal Drugs Market Research Report by Drug Category (Acid Neutralizers, Anti-Inflammatory, Antiemetic and Antinauseants, Biologics, and Laxatives and Anti-diarrheal), by Route of Administration (Oral, Parenteral, and Rectal), by Disease Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The...